The impact of fear and behaviour response to established and novel diseases
Avneet Kaur, Rebecca Tyson, Iain Moyles

TL;DR
This paper models how fear influences individual behavior and disease spread, revealing that the impact of fear on controlling epidemics varies depending on whether the disease is established or novel, with critical thresholds affecting epidemic dynamics.
Contribution
It introduces a dual-limit disease transmission model incorporating fear dynamics, highlighting how fear-induced behavior can either control or fail to control disease outbreaks depending on parameters.
Findings
Fear acquisition rate influences final fearful population size.
In established disease limit, fear has minimal impact on disease burden.
In novel disease limit, fear behavior can prevent or delay epidemic peaks.
Abstract
We analyze a disease transmission model that allows individuals to acquire fear and change their behaviour to reduce transmission. Fear is acquired through contact with infected individuals and through the influence of fearful individuals. We analyze the model in two limits: First, an Established Disease Limit (EDL), where the spread of the disease is much faster than the spread of fear, and second, a Novel Disease Limit (NDL), where the spread of the disease is comparable to that of fear. For the EDL, we show that the relative rate of fear acquisition to disease transmission controls the size of the fearful population at the end of a disease outbreak, and that the fear-induced contact reduction behaviour has very little impact on disease burden. Conversely, we show that in the NDL, disease burden can be controlled by fear-induced behaviour depending on the rate of fear loss.…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · Vaccine Coverage and Hesitancy · COVID-19 and Mental Health
